Clinical Trial Update: Glucose and Lipid Metabolism on Antipsychotic Medication [NA]

View source ↗

Summary

Clinical trial completed studying glucose and lipid metabolism effects of antipsychotic medication in schizophrenia-related conditions; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Schizoaffective Disorder
• Schizophrenia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Washington University School of Medicine | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2019-10-02